Neurologic Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Seizure Drug Boosts MS Patient Eyesight

New research suggests that a medication indicated to treat seizures could also reduce the risk of nerve damage and blindness in patients with multiple sclerosis (MS).

Air Pollution's Effects on the Brain

Long-term exposure to ambient air pollution may be linked to subtle changes in the brain that could lead to cognitive impairment, a new study suggests.

New Qudexy XR Monotherapy Age Range

The FDA has approved a Supplemental New Drug Application (sNDA) for Qudexy XR (topiramate; Upsher-Smith) extended-release capsules for monotherapy in patients ages 2 to less than 10 years old with partial onset (POS) or primary generalized tonic-clonic (PGTC) seizures.

Physicians Not Disclosing Alzheimer's Diagnosis

In a new report from the Alzheimer's Association, only 45% of patients with Alzheimer's disease or their caregivers stated that they were told the diagnosis by their physician and were more likely to be told the diagnosis after the disease had become more advanced.

Methionine May Promote Memory Loss

A diet rich in methionine may promote memory loss through increased netrin methylation, scientists from University of Louisville reported.

Targeted Immunotherapy for Alzheimer's

Memory problems associated with Alzheimer's disease may one day be reversed with targeted immunotherapy, according to a new study

Coffee's Neuroprotective Effects Supported

People who drink several cups of coffee every day may have a decreased risk of developing multiple sclerosis (MS).

Looking for a Job?

Access our job board to view over 1,​40​0 job openings throughout the US.

News

LVADs Linked to Decline in Cognitive Function, Worsening Health

Left ventricular assist devices might contribute to a decline in health or cognitive function in some patients.

Key Cytokine Discovery May Shape Future MS Treatment

A new study has confirmed that the cytokine granulocyte macrophage colony-stimulating factor (GM-CSF) likely plays a critical role in multiple sclerosis (MS) in humans, and has proposed a new reasoning for why treatment with interferon-beta is often effective in reducing MS attacks.

New Tx for Relapsing MS Moves Closer to Approval as FDA Accepts BLA for Review

The Food and Drug Administration (FDA) has accepted their Biologics License Application (BLA) for review for Zinbryta (daclizumab high-yield process; Biogen and AbbVie) in relapsing forms of multiple sclerosis (MS).

Comparing Working Memory in Women vs. Men After Concussions

New research from Taiwan uncovers more evidence that women may have a more difficult time recovering their memory after concussions.

FEATURES

Seizures Return After Initiating Vilazodone for MDD

Seizures Return After Initiating Vilazodone for MDD

Seizures induced by selective serotonin reuptake inhibitor (SSRI) use are rare and are more likely to be linked to larger doses and severe symptoms (such as those present in serotonin syndrome), but a new case study in the journal Pharmacotherapy described a patient that developed seizures after vilazodone treatment was initiated.

Is Roseroot a Reliable Alternative for Nervous System Ailments?

Is Roseroot a Reliable Alternative for Nervous System Ailments?

The perennial plant has been used to treat depression, muscle weakness and muscle fatigue.

Treating Traumatic Brain Injury in Young Athletes

Treating Traumatic Brain Injury in Young Athletes

Accurate identification, assessment and evaluation of concussions will enable clinicians to determine when it is safe for young athletes to return to competition.

Featured courses from mycme

Reconfirmed: No Autism Risk With MMR VaccinationExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Delayed Autism Diagnosis Common in Primary CareExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Clinical review - DeliriumExternal web site

Clinical review - Delirium

2.50 Credits

Sign Up for Free e-newsletters